Pay Less for Prescriptions: The 340B Drug Pricing Program

If you receive healthcare at a community health center, safety-net hospital, or other federally supported clinic, you may be eligible for dramatically reduced prescription drug prices through the 340B Drug Pricing Program—one of the most significant but least publicized healthcare savings programs in the United States. The 340B program requires pharmaceutical manufacturers to sell outpatient drugs to eligible healthcare organizations at discounts of 25% to 50% below retail prices. Those savings are then passed on to patients through lower copays, reduced cash prices, and sometimes free medications.

The program exists because Congress recognized that safety-net providers—the hospitals and clinics that serve low-income, uninsured, and vulnerable patients—need affordable drug prices to stretch their limited budgets and provide comprehensive care. Since its creation in 1992, the 340B program has grown to include over 50,000 covered entity sites, and 340B drug purchases now account for approximately 5% of all prescription drugs sold in the United States, with total spending exceeding $66 billion annually.

For individual patients, the impact can be life-changing. A medication that costs $400 per month at a retail pharmacy might cost $20 or less at a 340B-participating pharmacy. For patients managing chronic conditions that require multiple medications—diabetes, hypertension, HIV, cancer—the annual savings can reach thousands of dollars.

Opportunity Snapshot

How the 340B Program Works

The mechanics of 340B are invisible to most patients—you simply receive your prescriptions and notice that the prices are much lower than you expected. Behind the scenes, here is what happens:

Drug manufacturers agree to discounted pricing. As a condition of having their drugs covered by Medicaid, pharmaceutical companies must enter into pricing agreements with the federal government. Under these agreements, manufacturers sell covered outpatient drugs to eligible healthcare organizations (called “covered entities”) at or below the 340B ceiling price, which is calculated using a statutory formula.

Covered entities purchase drugs at 340B prices. Hospitals, health centers, and clinics that qualify as covered entities buy their outpatient drug inventory directly from manufacturers or through wholesalers at the discounted 340B price. This gives them access to medications at costs far below what retail pharmacies pay.

Patients receive medications at reduced costs. Covered entities use the savings from 340B pricing in various ways. Some operate on-site pharmacies where patients fill prescriptions at minimal cost. Others contract with retail pharmacies to dispense 340B drugs on their behalf. The savings may manifest as reduced copays for insured patients, lower cash prices for uninsured patients, or free medications for patients who cannot afford any payment.

Revenue supports safety-net services. When a covered entity fills a prescription for an insured patient, the insurer reimburses at the standard rate while the entity paid the lower 340B price. The margin between the acquisition cost and the reimbursement generates revenue that covered entities reinvest in patient care—funding free clinics, hiring additional staff, offering charity care, and expanding services to underserved populations.

Who Benefits from 340B

You may be benefiting from the 340B program without even knowing it. The program covers patients at a wide range of healthcare settings:

Federally Qualified Health Centers (FQHCs): Community health centers that serve patients on a sliding fee scale. If you receive care at an FQHC—the more than 1,400 organizations operating 15,000+ sites nationwide—your prescriptions may be filled at 340B prices.

Disproportionate Share Hospitals (DSH): Hospitals that serve a disproportionately high share of low-income and Medicaid patients. These are often the large urban and rural hospitals that serve as the healthcare safety net for their communities. Approximately one-third of all U.S. hospitals participate in 340B.

Ryan White HIV/AIDS Program grantees: Clinics and organizations that receive federal Ryan White funding to provide care and medications for people living with HIV/AIDS. The 340B program is critical for these providers, as antiretroviral medications can cost thousands of dollars per month at retail prices.

Other covered entities: Tuberculosis clinics, sexually transmitted disease clinics, family planning clinics, hemophilia treatment centers, black lung clinics, public housing primary care centers, homeless clinics, Urban Indian clinics, Native Hawaiian health centers, children’s hospitals, cancer hospitals, sole community hospitals, rural referral centers, and critical access hospitals.

Insured and uninsured patients alike. A common misconception is that 340B only benefits uninsured patients. In reality, any patient who receives care at a covered entity and fills prescriptions through the entity’s 340B pharmacy can benefit. Insured patients may see reduced copays or eliminated cost-sharing. Uninsured patients may receive medications at deep discounts or for free.

How to Access 340B Drug Pricing

Unlike most benefit programs, there is no separate application for 340B. You access the program simply by being a patient of a covered entity and filling your prescriptions through their designated pharmacy. Here is how to take advantage of it:

Step 1: Determine whether your healthcare provider is a 340B covered entity. The HRSA maintains a searchable database of all registered 340B covered entities at the Office of Pharmacy Affairs website. You can also ask your provider directly whether they participate in the 340B program.

Step 2: Ask about the 340B pharmacy. Many covered entities operate on-site pharmacies where 340B drugs are dispensed. Some partner with specific retail pharmacies through “contract pharmacy” arrangements. Ask your provider or their pharmacy staff where you should fill your prescriptions to receive 340B pricing.

Step 3: Fill your prescriptions at the designated pharmacy. When you fill your prescription at the covered entity’s pharmacy or designated contract pharmacy, the medication is dispensed at the 340B price. The pharmacy handles the pricing automatically—you do not need to present a special card or mention the program.

Step 4: Ask about patient assistance programs. If you are uninsured or underinsured and your medications are still expensive even at 340B prices, ask the pharmacy about additional patient assistance programs. Many covered entities have charity care policies, manufacturer copay assistance programs, or sliding fee scales that can further reduce your costs.

Understanding the Savings

The 340B discount varies by drug, but typical savings are significant:

Brand-name medications: 340B prices are typically 25% to 50% below the retail price. For high-cost specialty drugs used in cancer treatment, HIV care, or autoimmune disease management, the discount can be even steeper—sometimes 50% to 70% below retail.

Generic medications: While generics are already less expensive than brand-name drugs, 340B pricing can further reduce costs. A generic that costs $30 per month at a retail pharmacy might cost $5 to $10 at a 340B pharmacy.

Specialty medications: This is where 340B savings have the most dramatic impact. Specialty drugs for conditions like hepatitis C, multiple sclerosis, rheumatoid arthritis, or cancer can cost thousands to tens of thousands of dollars per month. At 340B prices, the same medications cost a fraction of the retail price, making previously unaffordable treatments accessible.

For example, a common insulin brand that costs $300 per month at a retail pharmacy might be available for $50 to $75 through a 340B pharmacy. An HIV antiretroviral regimen costing $2,500 per month at retail might cost $200 to $500 at a 340B site. These are not hypothetical savings—they represent the real-world impact of the program on patient affordability.

Limitations and Important Considerations

340B only covers outpatient drugs. Medications administered during an inpatient hospital stay are not subject to 340B pricing. The program covers only drugs prescribed for outpatient use and dispensed by an outpatient pharmacy.

You must be a patient of the covered entity. Casual or one-time visitors may not qualify. Most covered entities define “patient” as someone who has an established care relationship—meaning you have been seen by a provider at the entity, your medical records are maintained there, and the provider is responsible for your care. Simply filling a prescription written by an outside doctor may not qualify for 340B pricing.

Not all pharmacies are 340B pharmacies. If you take your prescription to a retail pharmacy that does not have a contract pharmacy arrangement with your covered entity, you will not receive 340B pricing. Always confirm which pharmacy to use with your provider.

The program does not have an individual income test. This is both a strength and a limitation. You do not need to prove low income to access 340B pricing. However, the savings you personally realize depend on the covered entity’s policies regarding how 340B savings are distributed to patients.

Some covered entities reinvest 340B revenue in services rather than individual patient discounts. While many pass savings directly to patients through reduced copays, others use the margin to fund free clinics, community health programs, or expanded services. Both uses serve the program’s mission, but the direct patient savings may vary by entity.

340B and Your Insurance

If you have insurance (Medicare, Medicaid, or private), your insurer’s formulary and cost-sharing rules still apply, but the covered entity may use 340B pricing to reduce or eliminate your copay. Here is how it works with different insurance types:

Medicare Part D: 340B entities can fill prescriptions for Medicare patients and retain the savings. Some entities pass these savings to patients as reduced copays. If you have a Medicare Part D plan, ask the 340B pharmacy whether your copay will be lower for 340B drugs.

Medicaid: Federal rules generally prohibit covered entities from purchasing drugs at 340B prices for Medicaid-covered prescriptions (to avoid “double dipping” on discounts). However, there are exceptions and workarounds depending on state policies and the entity’s billing practices.

Private insurance: Your copay may be reduced if the covered entity’s 340B pharmacy charges the insurer the standard rate and uses the 340B savings to offset your cost-sharing. The specifics depend on the entity’s financial assistance policies.

Uninsured patients: This is where 340B provides the most direct savings. Without insurance, you would typically pay the full retail price at a regular pharmacy. At a 340B pharmacy, you pay a price based on the entity’s discounted acquisition cost—often dramatically lower. Many 340B pharmacies offer sliding fee scales for uninsured patients, reducing costs even further.

History and Congressional Intent

The 340B program was created by the Veterans Health Care Act of 1992, signed by President George H.W. Bush. It was a direct response to a problem Congress identified: when the Medicaid Drug Rebate Program was enacted in 1990, it inadvertently caused drug prices to rise for safety-net providers that had previously received voluntary discounts from manufacturers. Congressional hearings found that prices for commonly used outpatient drugs at public hospitals increased by an average of 32% after the Medicaid rebate program disrupted the voluntary discount market.

Section 340B of the Public Health Service Act was the solution. By requiring manufacturers to provide statutory discounts to eligible safety-net providers as a condition of Medicaid participation, Congress ensured that the institutions serving America’s most vulnerable patients would have access to affordable medications regardless of market dynamics.

The program’s bipartisan support has kept it in place for over three decades, though it has faced ongoing debates about its scope, oversight, and accountability. HRSA’s Office of Pharmacy Affairs administers the program and oversees covered entity compliance.

Frequently Asked Questions

Do I need to apply for 340B benefits? No. There is no separate application. You access 340B pricing by being a patient of a covered entity and filling prescriptions at their designated pharmacy.

How do I know if my provider is a 340B entity? Ask your provider directly, or search the HRSA 340B OPAIS (Office of Pharmacy Affairs Information System) database online.

Can I use 340B pricing at any pharmacy? No. You must use the covered entity’s in-house pharmacy or a designated contract pharmacy. Ask your provider which pharmacy to use.

Is there a limit on how many prescriptions I can fill at 340B prices? There is no limit on the number of prescriptions, as long as they are prescribed by a provider at the covered entity for outpatient use.

Does 340B cover over-the-counter medications? No. The program covers only prescription outpatient drugs.

How to Get Started

1. Ask your healthcare provider if they participate in the 340B Drug Pricing Program
2. Ask which pharmacy is designated for 340B prescriptions
3. Fill your prescriptions at the designated 340B pharmacy
4. If you are uninsured, ask about the pharmacy’s sliding fee scale or patient assistance programs
5. Search the HRSA 340B database at hrsa.gov/opa to find covered entities near you

The 340B program quietly saves patients billions of dollars each year on prescription medications. If you receive care at a community health center, safety-net hospital, or other federally supported clinic, make sure you are filling your prescriptions through their 340B pharmacy to capture every dollar of savings available to you.